Cooper is one of approximately 40 sites in the United States and the only hospital in the Philadelphia region participating in a clinical trial for Boston Scientific’s WATCHMAN FLX™ device. The WATCHMAN FLX™ is the next generation of a potentially life-changing catheter-based (or non-surgically delivered) device designed to close the left atrial appendage in order to reduce the risk of stroke in certain patients with atrial fibrillation (AFib). Read more.
Cooper Resident Lourdes Alanis Shares Interventional Radiology “Day in the Life”
On Friday, September 28, 2018, Lourdes Alanis, a fourth-year resident with Cooper’s Diagnostic Radiology program, gave Instagram followers a look into the world of interventional radiology (IR). This opportunity was provided by the Society of Interventional Radiology (SIR), which highlighted six women in IR as part of a social media campaign in September celebrating Women in Medicine Month. Each physician shared photos on SIR’s Instagram, walking followers through their “day in the life” at various institutions across the country. Read more.
Update to Cooper Visiting Hours Policy
In our continuous effort to enhance patient care and improve the Cooper experience for our patients and employees, guest visiting hours at the hospital now end at 9 p.m., which was made effective Monday, September 24, 2018. This change is consistent with other hospitals in the region. Click here to see visiting hours throughout the hospital.
Reducing activities earlier on the patient care floors helps foster a healing environment and provides additional quiet time for patients to rest and sleep. Read more.
MD Anderson Cancer Center at Cooper Celebrates Five-Year Anniversary
MD Anderson Cancer Center at Cooper marked its five-year anniversary of serving the region at a celebration attended by elected officials, hospital leadership, and cancer survivors.
“This is another exciting day as MD Anderson at Cooper continues to transform cancer care for the people of South Jersey and the region,” said George E. Norcross III, Chairman of the Board of Trustees at Cooper University Health Care. Read more.
Subaru and the Leukemia & Lymphoma Society Deliver “Gestures of Hope” to Cancer Patients at MD Anderson Cancer Center at Cooper
Executives from Subaru of America’s corporate headquarters and the Leukemia & Lymphoma Society (LLS) delivered messages of hope and 100 specially made blankets to outpatients at MD Anderson at Cooper to help encourage patients and keep them warm as they continue their fight against cancer.
“This is such a generous and kind gesture from our friends from Subaru of America, and the Leukemia & Lymphoma Society,” said Adrienne Kirby, PhD, FACHE, Executive Chair and Chief Executive Officer at Cooper University Health Care. Read more.
Cooper Awarded the Blue Cross and Blue Shield Association’s (BCBSA) Blue Distinction® Center for Maternity Care Designation
To help prospective parents find hospitals that deliver quality maternity care, CareFirst BlueCross BlueShield announced that Cooper University Health Care has been awarded the Blue Cross and Blue Shield Association’s (BCBSA) Blue Distinction® Center for Maternity Care designation, a designation under the Blue Distinction Specialty Care program.
Nearly four million babies are born in the U.S. annually, making childbirth the most common cause of hospitalization. Read more.
Cooper Team Comes Through for #OperationBackpack
On Wednesday, August 29, 2018, the scholars of KIPP Cooper Norcross Academy at Lanning Square Primary and Whittier Middle Schools received backpacks full of new supplies for the start of their new school year.
#OperationBackpack is an annual fundraiser organized by The Cooper Foundation benefiting the students of Cooper’s neighborhood schools. Employees of Cooper University Health Care donate backpacks and school supplies so that every student scholar at KIPP Cooper Norcross Academy starts the school year ready to learn. Read more.
Cooper University Health Care Research Team Instrumental in Clinical Trials of New Drug for Rare Genetic Disorder
Caroline Eggerding, MD, Division Head, Pediatric Neurology and Development, led a research team at Cooper University Health Care that was instrumental in conducting clinical trials for a ground-breaking new drug approved earlier this year to treat phenylketonuria (PKU), a rare genetic disorder.
PKU is a rare genetic disorder in which the body is unable to metabolize phenylalanine, an amino acid found in almost every source of natural protein, as well as a number of sweeteners. Read more.
Non-Profit Organization Delivers Toys for Young Patients at Children’s Regional Hospital at Cooper
Former NJ State Senator Raymond Lesniak and representatives from the non-profit organization Toys for Hospitalized Children visited Children’s Regional Hospital at Cooper University Health Care to brighten the day of young patients with gifts of toys and music.
Toys for Hospitalized Children is a non-profit organization founded in 1953 to bring smiles and healing to sick children. Since its inception in 1953, Toys for Hospitalized Children has brought smiles to 950,000 children in 150 hospitals in 10 states with gifts and toys. Read more.
August 31 Is International Overdose Awareness Day
Cooper’s Addiction Medicine Program encourages staff and the community to take time on Friday, August 31, 2018, for International Overdose Awareness Day to learn more about addiction, its effect on families and the community, and efforts to reduce overdoses and death. The day is also an opportunity to stimulate discussion about evidence-based overdose prevention and drug policy.
International Overdose Awareness Day, established in 2001 in Australia and now recognized around the world, also acknowledges the grief felt by families and friends remembering those who have died or suffered permanent injury due to drug overdose. Read more.